3Romero-Rojas A,Reyes-Esparza J, Esparza-Parra S, et al. Immu nomo-dulatory properties of Mycoplasma Pulmonis. Ⅲ. Lympho eyte stimalation and cytokine production by Myeoplasma pulmonis products[J]. Int Immunopharmacol, 2001,1 (9-10) : 1699.
3Youn YS, Lee KY. Mycoplasma pneumoniae pneumonia in children [J]. Korean J Pediatr,2012,55 (2) :42-47.
4Smith LG. Mycoplasma pneumonia and its complications [J]. Infect Dis Clin North Am,2010,24( 1 ) :57-60.
5Narita M. Pathogenesis of extrapulmonary manifestations of Myeoplas- ma pneumoniae infection with special reference to pneumonia [J]. Infect Chemother, 2010,16 ( 3 ) : 162 - 169.
6Song Q, Xu BP, Shen KL. Effects of bacterial and viral co - infec- tions of mycoplasma pneumoniae pneumonia in children: analysis report from Beijing Children's Hospital between 2010 and 2014 [J]. Int J Clin Exp Meal,2015,8(9) :15666 -15674.
7Shu LH, Lu Q, Han LY, et al. SP - D, KL - 6, and HTI - 56 lev- els in children with mycoplasma pneumoniae pneumonia[J]. Int J Clin Exp Pathol,2015,8 (9) : 11185 - 11191.
8Olson D, Watkins LK, Demirjian A, et al. Outbreak of Mycoplasma pneumoniae - Associated Stevens - Johnson Syndrome [J]. Pediat- rics,2015,136(2 ) : e386 - e394.